Document Detail

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
MedLine Citation:
PMID:  16488907     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a life-threatening condition associated with ovarian stimulation. Its pathophysiology is unknown and its treatment continues to be empirical. Early (E)- and late (L)-OHSS occur in women at risk, though not in all cases. Vascular endothelial growth factor (VEGF) is related to increased vascular permeability in OHSS. We analysed the dynamics of the VEGF system in E- and L-OHSS. METHODS: A prospective cohort of women undergoing IVF-ICSI treatment were divided into groups. E-OHSS: Nonpregnant patients classified as women not at risk (group 1) (n = 11) and patients at risk who did not (group 2) (n = 18) and did (group 3) (n = 8) develop severe OHSS. Blood was drawn on the day of ovum retrieval (day 0) and 3, 6, 10 and 14 days later. L-OHSS: Single pregnancies classified as women who did not (group 4) (n = 8) and did develop (group 5) (n = 4) OHSS. Single pregnancies after oocyte donation (OD) (n = 4) were compared with groups 4 and 5 (IVF-ICSI). Blood was obtained weekly (weeks 4-12). Total VEGF (VEFG-A), free (f)-VEGF and soluble VEGF receptor 1 (sVEGFR-1) in plasma and in serum alpha2-macroglobulin (M) were also measured. RESULTS: Group 3 showed significantly (P < 0.05) higher VEFG-A and f-VEGF than group 1 on day 6 because of lower sVEGFR-1 secretion. Similarly, group 5 had significantly (P < 0.05) more VEFG-A and f-VEGF and less sVEGFR-1 than group 4. Oocyte donation was associated with decreased sVEGFR-1 secretion, and alpha2M was not relevant in OHSS development. CONCLUSION: In E- and L-OHSS, the ability to secrete sVEGFR-1 and bind VEGF seems to be the determinant factor in OHSS. f-VEGF acts locally in the ovary.
Elena Pau; Isabel Alonso-Muriel; Raul Gómez; Edurne Novella; Amparo Ruiz; Juan A García-Velasco; Carlos Simón; Antonio Pellicer
Related Documents :
10732117 - Production of embryos by assisted reproduction in the horse.
11679527 - Ultrastructural evaluation of recurrent and in-vitro maturation resistant metaphase i a...
9663767 - Principles of mammalian fertilization.
3119377 - Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilizati...
15800747 - Effects of maternal and embryo characteristics on post-fertilization provisioning in fi...
8841207 - Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, pree...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-02-17
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  21     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-25     Completed Date:  2006-11-09     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  1453-60     Citation Subset:  IM    
Instituto Valenciano de Infertilidad Foundation, University of Valencia, Valencia, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cohort Studies
Fertilization in Vitro / methods
Oocytes / metabolism
Ovarian Hyperstimulation Syndrome / blood*
Ovary / pathology
Sperm Injections, Intracytoplasmic / methods
Time Factors
Vascular Endothelial Growth Factor A / metabolism
Vascular Endothelial Growth Factor Receptor-1 / blood*
alpha-Macroglobulins / biosynthesis
Reg. No./Substance:
0/Vascular Endothelial Growth Factor A; 0/alpha-Macroglobulins; EC Endothelial Growth Factor Receptor-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and t...
Next Document:  Pedigree-drawing with R and graphviz.